Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

HARESH JHANGIANI

NPI
1578566998
CMS profile
252534
Location
FOUNTAIN VALLEY, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2019 · Entire year

$12,465.64

246 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2019 · entire year · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $7,342.50 4
Food and Beverage $4,098.73 232
Travel and Lodging $731.17 4
Education $293.24 6

By paying entity

PY2019 · entire year · sorted by reported total

Page 5 of 5; records 201–246 of 246 matching records. This page contains 46 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

HARESH JHANGIANI

NPI 1578566998 · CMS profile ID 252534

FOUNTAIN VALLEY, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 5 of 5; records 201–246 of 246 matching records. This page contains 46 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1578566998?year=2019&recipient=provider&page=5#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
HARESH JHANGIANI, NPI 1578566998, CMS profile ID 252534. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 5 of 5; records 201–246 of 246 matching records. This page contains 46 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1578566998?year=2019&recipient=provider&page=5#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
APA 7
IndustryPayments. (2026). HARESH JHANGIANI, NPI 1578566998, CMS profile ID 252534. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 5 of 5; records 201–246 of 246 matching records. This page contains 46 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1578566998?year=2019&recipient=provider&page=5#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
Bluebook
HARESH JHANGIANI, NPI 1578566998, CMS profile ID 252534, IndustryPayments, General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 5 of 5; records 201–246 of 246 matching records. This page contains 46 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e. https://industrypayments.org/provider/npi-1578566998?year=2019&recipient=provider&page=5#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2019 · Physicians and non-physician practitioners · CMS publication 2026-06-30

246 matching records · $12,465.64 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 246 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 201–246 of 246.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Bayer HealthCare Pharmaceuticals Inc. $21.8502/19/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 655963949 CMS
Merck Sharp & Dohme Corporation $20.0002/19/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695280223 CMS
Alexion Pharmaceuticals, Inc. $22.7902/18/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695617021 CMS
Amgen Inc. $22.4502/18/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662378644 CMS
PFIZER INC. $0.2202/18/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673316745 CMS
PFIZER INC. $4.0202/18/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673316777 CMS
PFIZER INC. $1.8502/17/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673738771 CMS
Merck Sharp & Dohme Corporation $15.5202/11/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695266989 CMS
PFIZER INC. $10.0402/11/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673315791 CMS
Janssen Biotech, Inc. $21.9102/08/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658502427 CMS
AMAG Pharmaceuticals, Inc. $22.1102/07/2019 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 698521471 CMS
Amgen Inc. $33.5002/06/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662378625 CMS
Merck Sharp & Dohme Corporation $17.7302/06/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695264633 CMS
Genentech USA, Inc. $20.6402/05/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681307633 CMS
Gilead Sciences, Inc. $12.6202/05/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681536287 CMS
AbbVie, Inc. $19.9502/01/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673603435 CMS
Incyte Corporation $3,650.0001/31/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 666249233 CMS
Incyte Corporation $50.0001/31/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 666249237 CMS
Incyte Corporation $24.0001/31/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 666249241 CMS
Incyte Corporation $29.0001/31/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 666249247 CMS
EISAI INC. $18.4401/30/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 696997179 CMS
PFIZER INC. $14.7301/29/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673314183 CMS
Seattle Genetics, Inc. $13.0001/28/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 678797975 CMS
Novartis Pharmaceuticals Corporation $22.6801/25/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 659607517 CMS
Celgene Corporation $13.2501/24/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673411821 CMS
Jazz Pharmaceuticals Inc. $17.5801/23/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 684539177 CMS
Jazz Pharmaceuticals Inc. $3.3301/23/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 684539181 CMS
E.R. Squibb & Sons, L.L.C. $0.1901/22/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 651466269 CMS
E.R. Squibb & Sons, L.L.C. $14.1901/22/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 651466283 CMS
Astellas Pharma US Inc $11.2401/19/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 655620483 CMS
Bayer HealthCare Pharmaceuticals Inc. $0.8101/18/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 655965615 CMS
Bayer HealthCare Pharmaceuticals Inc. $23.7801/18/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 655966579 CMS
Spectrum Pharmaceuticals Inc. $13.1001/18/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 639801835 CMS
Janssen Biotech, Inc. $25.6501/17/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658502423 CMS
Incyte Corporation $13.2001/14/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 666249093 CMS
Pharmacyclics LLC, An AbbVie Company $22.0201/14/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 665849998 CMS
AstraZeneca Pharmaceuticals LP $22.6301/11/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 685658817 CMS
Incyte Corporation $145.7701/11/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 666249251 CMS
Incyte Corporation $48.0701/11/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 666249255 CMS
Incyte Corporation $48.1101/11/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 666249259 CMS
Incyte Corporation $532.4001/11/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 666249263 CMS
Pharmacyclics LLC, An AbbVie Company $20.0401/10/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 665850231 CMS
Pharmacyclics LLC, An AbbVie Company $0.6601/10/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 665850247 CMS
Incyte Corporation $19.5701/07/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 666249097 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $19.0701/04/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 700416107 CMS
Clovis Oncology, Inc. $11.7001/03/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 688684769 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $12,465.64 246
PY2020 $9,878.60 235
PY2021 $14,611.01 343
PY2022 $8,101.36 347
PY2023 $6,874.86 335
PY2024 $12,475.96 310
PY2025 $12,349.22 221

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $210,906.42 22
PY2024 Principal investigator $79,449.02 28
PY2023 Principal investigator $20,186.20 8
PY2022 Principal investigator $57,022.06 17
PY2021 Principal investigator $35,042.77 11
PY2020 Principal investigator $150,073.99 38
PY2019 Recipient $2,151.04 1
PY2019 Principal investigator $116,960.46 25

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

22 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $88.99 09/30/2025 Non-covered Recipient Entity
Los Angeles Cancer Network
A Randomized, Double-Blind, Phase 3 Trial of Adagrasib plus Pembrolizumab plus Chemotherapy vs. Placebo plus Pembrolizumab plus Chemotherapy in Participants with Previously Untreated, Locally Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer with KRAS G12C Mutation (KRYSTAL-4) No dispute reported 06/30/2026 1235996177
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $2,437.84 08/07/2025 Non-covered Recipient Entity
Los Angeles Cancer Network
A Phase 3, Open-label, Randomized Study to Compare the Efficacy and Safety of Luspatercept vs Epoetin Alfa for the Treatment of Anemia Due to Revised International Prognostic Scoring System Very Low, Low, or Intermediate Risk Myelodysplastic Syndrome in Erythropoiesis-Stimulating Agent naive Participants who are Non-Transfusion Dependent No dispute reported 06/30/2026 1235996175
Principal investigator 1 Hexal AG $2,361.99 05/28/2025 Non-covered Recipient Entity
COMPASSIONATE CARE RESEARCH GROUP INC
CGME751A12101 No dispute reported 06/30/2026 1186348604
Principal investigator 1 AstraZeneca UK Limited $71,353.01 04/23/2025 Non-covered Recipient Entity
LOS ANGELES HEMATOLOGY ONCOLOGY MEDICAL GROUP
CAMBRIA-2 A Phase III, Open-Label, Randomised Study to Assess the Efficacy and Safety of Camizestrant (AZD9833, a Next Generation, Oral Selective Estrogen Receptor Degrader) vs Standard Endocrine Therapy (Aromatase Inhibitor or Tamoxifen) as Adjuvant Treatment for Patients With ER+/HER2- Early Breast Cancer and an Intermediate-high or High risk of Recurrence Who Have Completed Definitive Locoregional Treatment and Have No Evidence of Disease No dispute reported 06/30/2026 1185549359
Principal investigator 1 Hexal AG $2,207.19 03/31/2025 Non-covered Recipient Entity
COMPASSIONATE CARE RESEARCH GROUP INC
CGME751A12301 No dispute reported 06/30/2026 1186348522
Principal investigator 1 Hexal AG $2,355.54 03/31/2025 Non-covered Recipient Entity
COMPASSIONATE CARE RESEARCH GROUP INC
CGME751A12301 No dispute reported 06/30/2026 1186348526
Principal investigator 1 Hexal AG $2,582.58 03/31/2025 Non-covered Recipient Entity
COMPASSIONATE CARE RESEARCH GROUP INC
CGME751A12301 No dispute reported 06/30/2026 1186348532
Principal investigator 1 Hexal AG $2,146.56 03/31/2025 Non-covered Recipient Entity
COMPASSIONATE CARE RESEARCH GROUP INC
CGME751A12301 No dispute reported 06/30/2026 1186348536
Principal investigator 1 Hexal AG $2,421.33 03/31/2025 Non-covered Recipient Entity
COMPASSIONATE CARE RESEARCH GROUP INC
CGME751A12301 No dispute reported 06/30/2026 1186348540
Principal investigator 1 Hexal AG $2,554.20 03/31/2025 Non-covered Recipient Entity
COMPASSIONATE CARE RESEARCH GROUP INC
CGME751A12301 No dispute reported 06/30/2026 1186348550
Principal investigator 1 Hexal AG $2,730.93 03/31/2025 Non-covered Recipient Entity
COMPASSIONATE CARE RESEARCH GROUP INC
CGME751A12301 No dispute reported 06/30/2026 1186348556
Principal investigator 1 Hexal AG $2,146.56 03/31/2025 Non-covered Recipient Entity
COMPASSIONATE CARE RESEARCH GROUP INC
CGME751A12301 No dispute reported 06/30/2026 1186348560
Principal investigator 1 Hexal AG $2,146.56 03/31/2025 Non-covered Recipient Entity
COMPASSIONATE CARE RESEARCH GROUP INC
CGME751A12301 No dispute reported 06/30/2026 1186348564
Principal investigator 1 Hexal AG $2,488.41 03/31/2025 Non-covered Recipient Entity
COMPASSIONATE CARE RESEARCH GROUP INC
CGME751A12301 No dispute reported 06/30/2026 1186348656
Principal investigator 1 Hexal AG $4,166.70 03/31/2025 Non-covered Recipient Entity
COMPASSIONATE CARE RESEARCH GROUP INC
CGME751A12301 No dispute reported 06/30/2026 1186348658
Principal investigator 1 Hexal AG $2,021.43 03/31/2025 Non-covered Recipient Entity
COMPASSIONATE CARE RESEARCH GROUP INC
CGME751A12301 No dispute reported 06/30/2026 1186348660
Principal investigator 1 Hexal AG $2,421.33 03/31/2025 Non-covered Recipient Entity
COMPASSIONATE CARE RESEARCH GROUP INC
CGME751A12301 No dispute reported 06/30/2026 1186348662
Principal investigator 1 Hexal AG $30.64 02/19/2025 Non-covered Recipient Entity
COMPASSIONATE CARE RESEARCH GROUP INC
CGME751A12301 No dispute reported 06/30/2026 1186348652
Principal investigator 1 Hexal AG $169.92 02/19/2025 Non-covered Recipient Entity
COMPASSIONATE CARE RESEARCH GROUP INC
CGME751A12301 No dispute reported 06/30/2026 1186348654
Principal investigator 1 AstraZeneca UK Limited $101,959.11 02/14/2025 Non-covered Recipient Entity
LOS ANGELES CANCER NETWORK
CAMBRIA-1 A Phase III, Open-Label,Randomised Study to Assess the Efficacy and Safety of Extended Therapy with Camizestrant (AZD9833, a Next Generation, Oral Selective Estrogen Receptor Degrader) vs Standard Endocrine Therapy (Aromatase Inhibitor or Tamoxifen) in Patients with ER+/HER2 No dispute reported 06/30/2026 1185549361
Principal investigator 1 Hexal AG $30.64 01/14/2025 Non-covered Recipient Entity
COMPASSIONATE CARE RESEARCH GROUP INC
CGME751A12301 No dispute reported 06/30/2026 1186348488
Principal investigator 1 Hexal AG $84.96 01/14/2025 Non-covered Recipient Entity
COMPASSIONATE CARE RESEARCH GROUP INC
CGME751A12301 No dispute reported 06/30/2026 1186348490